Clinical Trial Update: Efficacy and Safety of Flos Gossypii Flavonoids Tablet in the Treatment of Alzheimer's Disease [Phase 2]

View source ↗

Summary

A completed Phase 2 trial evaluated Flos Gossypii flavonoids tablet in Alzheimer's disease, assessing efficacy and safety. The trial was sponsored by Capital Me…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Alzheimer Disease

Drugs mentioned

• Flos Gossypii Flavonoids Tablet (Flavonoids derived from Flos Gossypii)

Snippet

Sponsor: Capital Medical University | Conditions: Alzheimer Disease | Phase 2 | Status: COMPLETED